Chemotherapy of advanced non-Hodgkin's lymphoma (Q41489810)

1 October 2017

Chemotherapy of advanced non-Hodgkin's lymphoma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A583032

13 July 2022

1 reference

https://api.crossref.org/works/10.1016/S0308-2261(79)80010-7

23 July 2023

author name string

A. T. Skarin

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A583032

13 July 2022

G. P. Canellos

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A583032

13 July 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=583032

13 July 2022

publication date

1 October 1979

1 reference

full work available at URL

1 October 2017

https://api.elsevier.com/content/article/PII:S0308226179800107?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S0308-2261(79)80010-7

https://api.elsevier.com/content/article/PII:S0308226179800107?httpAccept=text/plain

23 July 2023

1 reference

https://api.crossref.org/works/10.1016/S0308-2261(79)80010-7

23 July 2023

published in

Clinics in haematology

1 reference

1 October 2017

8

1 reference

1 October 2017

3

1 reference

1 October 2017

667-684

1 reference

Combination chemotherapy in non-Hodgkin's lymphoma: results of long-term followup

1 October 2017

1

1 reference

https://api.crossref.org/works/10.1016/S0308-2261(79)80010-7

Non-hodgkin's lymphoma, poorly differentiated lymphocytic and mixed cell types.Results of sequential staging procedures, response to therapy, and survival of 100 patients

23 July 2023

2

1 reference

https://api.crossref.org/works/10.1016/S0308-2261(79)80010-7

Approaches to the treatment of acute leukemia and lymphoma in adults

23 July 2023

3

1 reference

https://api.crossref.org/works/10.1016/S0308-2261(79)80010-7

Protected environment-prophylactic antibiotic program for malignant lymphoma. Randomized trial during chemotherapy to induce remission

23 July 2023

4

1 reference

https://api.crossref.org/works/10.1016/S0308-2261(79)80010-7

Non-cross-resistant combinations in stage IV non-Hodgkin's lymphomas

23 July 2023

5

1 reference

https://api.crossref.org/works/10.1016/S0308-2261(79)80010-7

Chemotherapy of the non-Hodgkin's lymphomas

23 July 2023

8

1 reference

https://api.crossref.org/works/10.1016/S0308-2261(79)80010-7

Chemotherapy of non-Hodgkin's lymphoma: 10 years' experience in the Southwest Oncology Group

23 July 2023

9

1 reference

https://api.crossref.org/works/10.1016/S0308-2261(79)80010-7

Advanced diffuse histiocytic lymphoma, a potentially curable disease

23 July 2023

11

1 reference

https://api.crossref.org/works/10.1016/S0308-2261(79)80010-7

1.3-Bis(2-chloroethyl)-1-nitrosourea(BCNU), cyclophosphamide, vincristine- and prednisone-(BCOP): A new therapeutic regimen for diffuse histiocytic lymphoma

23 July 2023

12

1 reference

https://api.crossref.org/works/10.1016/S0308-2261(79)80010-7

BCNU with and without cyclophosphamide, vincristine, and prednisone (COP) and cycle-active therapy in non-Hodgkin's lymphoma

23 July 2023

13

1 reference

https://api.crossref.org/works/10.1016/S0308-2261(79)80010-7

Combination chemotherapy of diffuse histiocytic lymphoma with cyclophosphamide, adriamycin, vincristine and prednisone (CHOP)

23 July 2023

14

1 reference

https://api.crossref.org/works/10.1016/S0308-2261(79)80010-7

Malignant lymphoma, small lymphocytic type: a clinicopathologic study of 84 cases with suggested criteria for intermediate lymphocytic lymphoma

23 July 2023

15

1 reference

https://api.crossref.org/works/10.1016/S0308-2261(79)80010-7

Comparison of intensive versus moderate chemotherapy of lymphocytic lymphomas: a progress report

23 July 2023

16

1 reference

https://api.crossref.org/works/10.1016/S0308-2261(79)80010-7

Survival of nodular versus diffuse pattern lymphocytic poorly differentiated lymphoma

23 July 2023

17

1 reference

https://api.crossref.org/works/10.1016/S0308-2261(79)80010-7

Prognostic factors for advanced diffuse histiocytic lymphoma following treatment with combination chemotherapy

23 July 2023

18

1 reference

https://api.crossref.org/works/10.1016/S0308-2261(79)80010-7

Combined modality therapy for advanced, diffuse lymphocytic and histiocytic lymphomas

23 July 2023

20

1 reference

https://api.crossref.org/works/10.1016/S0308-2261(79)80010-7

Diffuse well-differentiated lymphocytic lymphoma (DLWD).Response and survival

23 July 2023

21

1 reference

https://api.crossref.org/works/10.1016/S0308-2261(79)80010-7

Non-Hodgkin's lymphomas. IV. Clinicopathologic correlation in 405 cases.

23 July 2023

23

1 reference

https://api.crossref.org/works/10.1016/S0308-2261(79)80010-7

Combination versus successive single agent chemotherapy in lymphocytic lymphoma

23 July 2023

24

1 reference

https://api.crossref.org/works/10.1016/S0308-2261(79)80010-7

Combination therapy of the lymphomas

23 July 2023

25

1 reference

https://api.crossref.org/works/10.1016/S0308-2261(79)80010-7

Treatment of histiocytic and mixed lymphomas.A comparison of two, three and four drug chemotherapy

23 July 2023

26

1 reference

https://api.crossref.org/works/10.1016/S0308-2261(79)80010-7

Comparison of combined and single-agent chemotherapy in non-Hodgkin's lymphoma of favourable histological type

23 July 2023

27

1 reference

https://api.crossref.org/works/10.1016/S0308-2261(79)80010-7

Combination chemotherapy for advanced non-Hodgkin's lymphoma of unfavourable histology

23 July 2023

28

1 reference

https://api.crossref.org/works/10.1016/S0308-2261(79)80010-7

Immunologic characterization of human malignant lymphomas

23 July 2023

29

1 reference

https://api.crossref.org/works/10.1016/S0308-2261(79)80010-7

Curability of non-Hodgkin's lymphomas

23 July 2023

32

1 reference

https://api.crossref.org/works/10.1016/S0308-2261(79)80010-7

Hydroxyldaunomycin (Adriamycin) combination chemotherapy in malignant lymphoma

23 July 2023

33

1 reference

https://api.crossref.org/works/10.1016/S0308-2261(79)80010-7

Malignant lymphoma, lymphoblastic

23 July 2023

34

1 reference

https://api.crossref.org/works/10.1016/S0308-2261(79)80010-7

Non-hodgkin's lymphomas.A clinicopathologic study comparing two classifications

23 July 2023

35

1 reference

https://api.crossref.org/works/10.1016/S0308-2261(79)80010-7

Overview of four clinical studies of chemotherapy for stage III and IV non-Hodgkin's lymphomas by the Cancer and Leukemia Group B

23 July 2023

36

1 reference

https://api.crossref.org/works/10.1016/S0308-2261(79)80010-7

Chemotherapy of the non-Hodgkin's lymphomas: the Stanford experience

23 July 2023

37

1 reference

https://api.crossref.org/works/10.1016/S0308-2261(79)80010-7

No Initial Therapy for Stage III and IV Non-Hodgkin's Lymphomas of Favorable Histologic Types

23 July 2023

38

1 reference

https://api.crossref.org/works/10.1016/S0308-2261(79)80010-7

Convoluted lymphocytic lymphoma in adults: a clinicopathologic entity

23 July 2023

42

1 reference

https://api.crossref.org/works/10.1016/S0308-2261(79)80010-7

Non-Hodgkin's lymphoma: Patterns of relapse from complete remission after combination chemotherapy

23 July 2023

43

1 reference

https://api.crossref.org/works/10.1016/S0308-2261(79)80010-7

Bleomycin, adriamycin, cyclophosphamide, vincristine, and prednisone (BACOP) combination chemotherapy in the treatment of advanced diffuse histiocytic lymphoma

23 July 2023

44

1 reference

https://api.crossref.org/works/10.1016/S0308-2261(79)80010-7

Combination chemotherapy of advanced lymphocytic lymphoma:Importance of histologic classification in evaluating response

23 July 2023

46

1 reference

https://api.crossref.org/works/10.1016/S0308-2261(79)80010-7

New agents and combination chemotherapy of non-Hodgkin's lymphoma

23 July 2023

47

1 reference

https://api.crossref.org/works/10.1016/S0308-2261(79)80010-7

Combination chemotherapy of advanced non-Hodgkin lymphoma with bleomycin, adriamycin, cyclophosphamide, vincristine, and prednisone (BACOP)

23 July 2023

48

1 reference

https://api.crossref.org/works/10.1016/S0308-2261(79)80010-7

High-dose methotrexate with folinic acid in the treatment of advanced non-Hodgkin lymphoma including CNS involvement

23 July 2023

49

1 reference

https://api.crossref.org/works/10.1016/S0308-2261(79)80010-7

Combination chemotherapy of lymphomas other than Hodgkin's disease

23 July 2023

51

1 reference

https://api.crossref.org/works/10.1016/S0308-2261(79)80010-7

Advanced lymphocytic lymphoma: randomized comparisons of chemotherapy and radiotherapy, alone or in combination

23 July 2023

55

1 reference

https://api.crossref.org/works/10.1016/S0308-2261(79)80010-7

Treatment results of 54 American patients with Burkitt's lymphoma are similar to the African experience

23 July 2023

56

1 reference

https://api.crossref.org/works/10.1016/S0308-2261(79)80010-7

23 July 2023

Identifiers

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=583032

13 July 2022

1 reference